2007
DOI: 10.1016/j.jhep.2007.03.025
|View full text |Cite
|
Sign up to set email alerts
|

Modulation of MAPK pathways and cell cycle by replicating hepatitis B virus: Factors contributing to hepatocarcinogenesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
65
1
1

Year Published

2010
2010
2015
2015

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 61 publications
(72 citation statements)
references
References 44 publications
(50 reference statements)
3
65
1
1
Order By: Relevance
“…Relationship between MTDH expression and clinicopathological parameters in patients with HBV-related HCC. (34)(35)(36). Additionally, HBx has been shown to activate the transcription factors NF-κB (37) and AP-1 (38).…”
Section: Discussionmentioning
confidence: 99%
“…Relationship between MTDH expression and clinicopathological parameters in patients with HBV-related HCC. (34)(35)(36). Additionally, HBx has been shown to activate the transcription factors NF-κB (37) and AP-1 (38).…”
Section: Discussionmentioning
confidence: 99%
“…The results of some studies have shown that cell cycle progression can be altered in cells that contain replicating HBV, and the status of cell proliferation pathways can also affect HBV replication in some experimental systems (reviewed in reference 41). Studies that examined the effect of HBV replication on the cell cycle in Huh7 cells, a human hepatoma cell line, and primary marmoset hepatocytes demonstrated that in the context of HBV replication, these cells stall in G 2 phase (17). The results of a different study demonstrated that entry into S phase was decreased in Huh7 cells and HepG2.2.15 cells, human hepatoblastoma HepG2 cells that contain an integrated HBV genome and can produce infectious HBV (23).…”
mentioning
confidence: 99%
“…Studies of Chang liver cells, HepG2 cells, NIH 3T3 cells, and HL-7702 cells suggested that HBx can induce arrested cells to enter the cell cycle, enter the cell cycle but stall in S phase, or progress through the cell cycle more rapidly (4,5,10,16,34,37,72). HBx can also modulate the levels of p16, p21, p27, cyclin D1, cyclin A, and cyclin B1; activate the p21 promoter; and increase the activity of cyclin-dependent kinase 2 (CDK2) in various cell lines and primary hepatocytes, although the precise effects of HBx varied in different experimental conditions (2,17,25,36,37,45,47,48,50). Andrisani's group has provided direct support for the notion that HBx can have different effects on cell proliferation pathways depending on specific cellular characteristics (37).…”
mentioning
confidence: 99%
“…However, Ras mutations that could account for sustained pathway activation are rare in human HCCs (Min et al, 2010). One explanation for constistutive ERK activation in HCCs can be that HBV or HCV viral infection interferes and activates the ERK signaling cascade facilitating thus hepatocarcinogenesis (Chin et al, 2007;Zhao et al, 2005). Another reason may lie with the fact that there is global suppression of negative regulators that control the ERK signaling cascade in HCC cell lines.…”
Section: Erk Pathway and Hccmentioning
confidence: 99%